grantDOI: https://doi.org/10.54464/pc.gr.160964 studyName: Is RasL11A a mechanism for cutaneous neurofibromas regression dataStatus: Under Embargo initiative: Biology and Therapeutic Development for Cutaneous Neurofibromas studyLeads: Katherine Gurdziel Raymond Mattingly studyStatus: Active diseaseFocus: Neurofibromatosis type 1 grantEndDate: 1790726400000 institutions: Wayne State University fundingAgency: NTAP manifestation: Cutaneous Neurofibroma embargoEndDate: 1830124800000 grantStartDate: 1696118400000 studyFileviewId: syn53974926 syn53974915 syn61249860 syn53974916 syn62655803 syn62655888 syn53974926 syn53974917 syn55190728 syn55191086
Drop files to upload
Is RasL11A a mechanism for cutaneous neurofibromas regression page is loading…